Ventolin vs. Singulair
See how Ventolin and Singulair compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Ventolin is a fast-acting rescue inhaler used to relieve sudden asthma symptoms, while Singulair is a daily pill taken to prevent asthma and allergy symptoms over time.
Ventolin works within minutes but only lasts a few hours, so it cannot replace a daily controller medication like Singulair.
Singulair carries an FDA boxed warning for serious mood and behavior changes, a risk Ventolin does not share.
Ventolin vs. Singulair Drug Summary
Ventolin
Ventolin (albuterol sulfate) is a short-acting beta2-agonist bronchodilator inhaler used to treat or prevent sudden asthma symptoms in people 4 and older. It is inhaled directly into the lungs using a metered-dose inhaler, working within minutes to open narrowed airways.
Singulair
Singulair (montelukast sodium) is a leukotriene receptor antagonist taken as a daily oral tablet, chewable, or granules to prevent asthma symptoms and relieve seasonal or year-round allergy symptoms. It does not act fast enough to treat a sudden asthma attack and is meant for long-term control.
Ventolin vs. Singulair Side Effects
Ventolin
Singulair
Ventolin vs. Singulair Dosage
Ventolin
Singulair
| STAGE | DOSE | WHEN |
| Starting dose | 1 inhalation every 4 hours | At the start |
| Maximum dose | 2 inhalations pre-exercise | If needed |
| Dose changes | 1 increase | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 4 mg once daily | At the start |
| Maximum dose | 10 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Ventolin
| STAGE | DOSE | WHEN |
| Starting dose | 1 inhalation every 4 hours | At the start |
| Maximum dose | 2 inhalations pre-exercise | If needed |
| Dose changes | 1 increase | As tolerated |
Singulair
| STAGE | DOSE | WHEN |
| Starting dose | 4 mg once daily | At the start |
| Maximum dose | 10 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Ventolin vs. Singulair Indications
Ventolin
Ventolin is FDA-approved to treat or prevent sudden bronchospasm caused by reversible airway disease in people 4 years and older. It is also approved to prevent bronchospasm triggered by exercise.
Treats sudden asthma attacks and bronchospasm
Prevents exercise-induced bronchospasm
Approved for ages 4 and up
Provides rapid relief within minutes
Singulair
Singulair is FDA-approved for the long-term prevention and control of asthma symptoms, not for treating an attack in progress. It also treats seasonal and year-round allergic rhinitis and helps prevent exercise-induced bronchoconstriction.
Prevents and controls chronic asthma symptoms
Prevents exercise-induced bronchoconstriction
Relieves seasonal allergic rhinitis symptoms
Relieves perennial (year-round) allergy symptoms
Ventolin vs. Singulair Pros and Cons
Ventolin
Ventolin acts within minutes to open airways during an asthma attack, making it the standard rescue option, but it does not address the underlying inflammation that drives asthma over time. Generic albuterol HFA inhalers are widely available and often cost far less than brand-name Singulair.
Pros
Starts working within minutes for acute symptoms
Generic versions are widely available
Roughly $28 to $45 per inhaler without insurance
Long track record of safe use since 1981
Cons
Does not treat underlying airway inflammation
Not a substitute for daily controller medication
Overuse carries a risk of serious cardiac effects
Not approved for children under 4
Singulair
Singulair offers a convenient once-daily pill for people who want to avoid inhaler technique altogether, and it doubles as an allergy treatment for those with both asthma and rhinitis. It carries a boxed warning for neuropsychiatric side effects and costs significantly more than generic albuterol.
Pros
Once-daily oral dosing, no inhaler technique needed
Also treats seasonal and year-round allergies
Available as chewable tablets for young children
Convenient for patients who dislike inhalers
Cons
Boxed warning for suicidal thoughts and behavior
Cannot be used to stop an active asthma attack
Roughly $289 to $375 per month without insurance
Risk of Churg-Strauss syndrome reported
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.